Home / World Marketplace / Global Corporate Affairs / Archive by category Launches & Unveilings (Page 75)

Archive by category Launches & Unveilings

The World’s Most Attractive Investment Migration Programs in 2025

LONDON, Feb. 25, 2025 (Korea Bizwire) – Malta retains 1st place in the 2025 Global Citizenship Program Index for the 10th consecutive year, while Greece reaches the top of the 2025 Global Residence Program Index for the first time, highlighting the dominance of European residence and citizenship by investment programs on Henley & Partners’ annual rankings of the most important investment migration programs in the world. The firm onboarded clients from [...]

Teledyne e2v announces new high-speed sensor with extended sensitivity in NIR wavelengths

GRENOBLE, France, Feb. 25, 2025 (Korea Bizwire) – Teledyne e2v, a Teledyne Technologies [NYSE: TDY] company and global innovator of imaging solutions, introduces Lince5M™ NIR, a state-of-the-art high-speed CMOS image sensor. Leveraging Teledyne e2v’s advanced imaging technologies, this new sensor delivers enhanced performance in both visible and near-infrared (NIR) wavelengths, making it ideal for a wide [...]

Mavenir and Terrestar Achieve Industry First Satellite Voice Over NB-IoT Call in NTN Mode

Breakthrough deployable via software upgrade to existing GEO satellites using available S-band spectrum to allow operators to monetize NTN services immediately RICHARDSON, Texas, Feb. 24, 2025 (Korea Bizwire) – Mavenir, the cloud-native network infrastructure provider building the future of networks, and Terrestar Solutions Inc., Canada’s premier mobile satellite operator, have achieved a groundbreaking milestone by [...]

Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. H5 avian influenza is a highly contagious and notifiable zoonotic disease, that is currently having a heavy impact on the poultry industry, farmers, and international trade worldwide. Administration at the [...]

Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars in US Strengthens US immunology portfolio and increases access to biologics for patients suffering from chronic inflammatory diseases, such as psoriasis and psoriatic arthritis [...]

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different doses New endpoints presented include findings on clinical and endoscopic outcomes and histological- endoscopic mucosal improvement Findings to form the basis [...]

ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption

ORLANDO, Fla., Feb. 21, 2025 (Korea Bizwire) – ThreatLocker®, a global leader in Zero Trust cybersecurity, has unveiled new solutions that further advance its platform’s security and efficiency. The announcement was made at Zero Trust World 2025 in Orlando, Florida. Designed to tackle the evolving threat landscape and the increasing complexity of cybersecurity, these innovations [...]

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is the second biosimilar to launch in the U.S. under the Teva and Alvotech strategic partnership, which includes nine products SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and [...]

Sport Business Global Golf Report: PGA Tour adapts to new challenges as women’s game grows

The report highlights the PGA Tour’s strategic moves to secure its future, including the launch of PGA Enterprises LONDON, Feb. 21, 2025 (Korea Bizwire) – The world of professional golf is evolving rapidly, with the PGA Tour at the forefront of innovation and adaptation. According to the latest Global Golf Report by Sport Business, the sport [...]

Bitget Launches Exclusive Campaign for FTX Creditors with up to $2,500 in Incentives

VICTORIA, Seychelles, Feb. 19, 2025 (Korea Bizwire) – Bitget, the leading cryptocurrency exchange and Web3 company, has announced an exclusive promotion for FTX creditors effective from February 17th to March 4th. Following the recent events surrounding FTX, Bitget recognizes the challenges faced by creditors and is committed to supporting the community. This special promotion is designed [...]